Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (6)
  • 2024 (4)
  • 2023 (9)
  • 2022 (1)
  • 2021 (2)

Subject

  • Drug Trafficking (386)
  • Synthetic drugs (182)
  • Arrests/Convictions - Major (59)
  • Fake Pills (48)
  • Seizures (Drugs/Property) (48)
  • OCDETF/Task Force (46)
  • Guilty Plea (43)
  • Guns/Weapons (37)
  • Fentanyl Awareness (31)
  • One Pill Can Kill (28)
  • Money Laundering (24)
  • Prescription Drugs (24)
  • Gangs (19)
  • Major Law Enforcement Operation (19)
  • Overdose (16)
  • Pharmaceuticals/Pharmacists/Physicians (14)
  • Extraditions (10)
  • Fentanyl Free America (9)
  • Take Back Day (8)
  • Task Forces/Task Force Officers (5)
  • Outreach/Drug Prevention (4)
  • Narcoterrorism (3)
  • Congressional Affairs (2)
  • Dark Web- Internet Trafficking (2)
  • HIDTA (2)
  • Press Conferences (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Campaigns (1)
  • Cartel (1)
  • Critical Incident (1)
  • International/Foreign Operations (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Diversion Division (23)

Drug Name

  • Opioids (2)
  • Oxycodone (1)

Field Division

  • New England (35)
  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • El Paso (8)
  • New Orleans (8)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Houston (16)
  • San Francisco (7)
Clear All Results
23 Results - Showing 1 to 10
PRESS RELEASE

Laredo Pharmacist Pays Six Figures to Settle Controlled Substance Act Violations

HOUSTON – The owner of Martinez Pharmacy in Laredo has agreed to pay $750,000 to resolve allegations his pharmacy violated federal recordkeeping and dispensing requirements, announced Drug Enforcement Administration (DEA) Special Agent in Charge Miguel Madrigal of the San Antonio Division and U.S. Attorney Nicholas J. Ganjei. Antonio Martinez Jr...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
PRESS RELEASE

San Antonio Man Sentenced to 28 Years in Federal Prison for Armed Pharmacy Robberies

SAN ANTONIO – A San Antonio man was sentenced to 339 months in federal prison for three counts of pharmacy robbery and three counts of brandishing a firearm during and in relation to a crime of violence. According to court documents, from October to December 2020, Atseko Factor, 40, and...
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster